Business Description
Nyxoah SA
ISIN : BE0974358906
Share Class Description:
STU:5YI: Ordinary SharesTotal Employee Number:
154Compare
Compare
Traded in other countries / regions
NYXH.BelgiumNYXH.USA5YI.GermanyNYXHb.UK IPO Date
2020-12-23Description
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.74 | |||||
Equity-to-Asset | 0.37 | |||||
Debt-to-Equity | 0.98 | |||||
Debt-to-EBITDA | -0.47 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -5.74 | |||||
Beneish M-Score | -1.46 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 30.3 | |||||
3-Year EBITDA Growth Rate | -26.3 | |||||
3-Year EPS without NRI Growth Rate | -21.6 | |||||
3-Year FCF Growth Rate | -3 | |||||
3-Year Book Growth Rate | -37.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 46.01 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 124.74 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 51.46 | |||||
9-Day RSI | 48.92 | |||||
14-Day RSI | 45.42 | |||||
3-1 Month Momentum % | -45.38 | |||||
6-1 Month Momentum % | -72.26 | |||||
12-1 Month Momentum % | -80.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.99 | |||||
Quick Ratio | 0.88 | |||||
Cash Ratio | 0.63 | |||||
Days Inventory | 307.86 | |||||
Days Sales Outstanding | 80.34 | |||||
Days Payable | 245.54 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -18.5 | |||||
Shareholder Yield % | -6.12 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 60.71 | |||||
Operating Margin % | -540.23 | |||||
Net Margin % | -545.69 | |||||
EBITDA Margin % | -490.89 | |||||
FCF Margin % | -493.14 | |||||
OCF Margin % | -469.8 | |||||
ROE % | -138.39 | |||||
ROA % | -74.41 | |||||
ROIC % | -116.99 | |||||
3-Year ROIIC % | -138.42 | |||||
ROC (Joel Greenblatt) % | -1199.72 | |||||
ROCE % | -98.53 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 3.96 | |||||
PB Ratio | 1.82 | |||||
EV-to-EBIT | -1.96 | |||||
EV-to-EBITDA | -2.11 | |||||
EV-to-Revenue | 10.34 | |||||
EV-to-Forward-Revenue | 4.06 | |||||
EV-to-FCF | -2.1 | |||||
Price-to-GF-Value | 0.06 | |||||
Earnings Yield (Greenblatt) % | -51.02 | |||||
FCF Yield % | -50.63 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nyxoah SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 15.328 | ||
| EPS (TTM) (€) | -2.136 | ||
| Beta | 1.0849 | ||
| 3-Year Sharpe Ratio | -0.27 | ||
| 3-Year Sortino Ratio | -0.43 | ||
| Volatility % | 65.6 | ||
| 14-Day RSI | 45.42 | ||
| 14-Day ATR (€) | 0.171905 | ||
| 20-Day SMA (€) | 1.4436 | ||
| 12-1 Month Momentum % | -80.91 | ||
| 52-Week Range (€) | 1.074 - 8.2 | ||
| Shares Outstanding (Mil) | 100.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nyxoah SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nyxoah SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-05 | In 113 days | ||
| Third quarter earnings results for 2026 | 2026-11-05 | In 113 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-05 | In 21 days | ||
| Second quarter earnings results for 2026 | 2026-08-05 | In 21 days | ||
| Investor and Analyst Day | 2026-07-08 10:00 | 1.46 (-4.33%) | ||
| General meeting for 2026 | 2026-06-10 14:00 | 1.16 (-12.54%) | ||
| Guidance call for 2026 | 2026-05-13 17:15 | 2.58 (-1.34%) | ||
| First quarter earnings conference call for 2026 | 2026-05-12 16:30 | 2.64 (+3.33%) | ||
| First quarter earnings results for 2026 | 2026-05-12 | 2.64 (+3.33%) | ||
| Annual report for 2025 | 2026-03-26 | 2.49 (-4.60%) |
Show
Entries
Nyxoah SA Frequently Asked Questions
What is Nyxoah SA(STU:5YI)'s stock price today?
The current price of STU:5YI is €1.49. The 52 week high of STU:5YI is €8.20 and 52 week low is €1.07.
When is next earnings date of Nyxoah SA(STU:5YI)?
The next earnings date of Nyxoah SA(STU:5YI) is 2026-08-05.
Does Nyxoah SA(STU:5YI) pay dividends? If so, how much?
Nyxoah SA(STU:5YI) does not pay dividend.
Press Release
Articles on Nyxoah SA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers